Competition law and policy in the Japanese pharmaceutical sector / Akira Negishi, Masako Wakui, Naoko Mariyama, editors.
Negishi, Akira.; Wakui, Masako, 1969-; Mariyama, Naoko.
2022
KNX3242
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Competition law and policy in the Japanese pharmaceutical sector / Akira Negishi, Masako Wakui, Naoko Mariyama, editors.
ISBN 9811678146
9789811678141 (electronic bk.)
9811678138
9789811678134
DOI https://doi.org/10.1007/978-981-16-7814-1
Imprint Singapore : Springer, 2022.
Language English
Description 1 online resource (252 pages)
Other Standard Identifiers 10.1007/978-981-16-7814-1 doi
Call Number KNX3242
Dewey Decimal Classification 343.5207/21
Summary This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides one-stop shopping for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
Bibliography, etc. Note Includes bibliographical references and index.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed February 23, 2022).
Added Author Negishi, Akira.
Wakui, Masako, 1969-
Mariyama, Naoko.
Series Kobe University monograph series in social science research.
Available in Other Form Competition Law and Policy in the Japanese Pharmaceutical Sector.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Preface
PART I HEALTHCARE AND PHARMACEUTICALS: INNOVATION AND REGULATION IN JAPAN
Regulation and Competition in the Pharmaceutical Industry in Japan
Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a Declining Population
Drug Regulation in Japan
Collaboration between the Patent System and Pharmaceutical Regulations for Drug-discovery Innovation in Japan
Corruption and Conflicts of Interest in the Pharmaceutical Market: Regulation of Pharmaceutical Companies Gift-giving Practices
PART II THE JAPANESE ANTIMONOPOLY ACT AND ITS RELATION TO THE PHARMACEUTICAL INDUSTRY
Antimonopoly Act and Its Application to the Pharmaceutical Industry in Japan
Horizontal Cooperation and Alliances amongst Pharmaceutical Companies and the Japanese Antimonopoly Act
Merger Regulations in the Japanese Pharmaceutical Industry
Pay-for-delay Agreements in Japan
No Challenge Clauses in the Pharmaceutical Industry in Japan
Will Authorised Biologics deter Biosimilars? -Utilising JFTCs expertise in drug pricing
PART III AN ECONOMIC ANALYSIS OF THE PHARMACEUTICAL INDUSTRY AND TRADE PRACTICES IN JAPAN
The Pharmaceutical Industry in Japan: A History of Its Development
Trade Practices in the Japanese Pharmaceutical Market: A Simulation Analysis of Improvement Policies.

Browse Subjects

Show more subjects...

Statistics

from
to
Export